What type of study is this?

This is a Human Clinical Trial study (also classified as: Pre-Registered Trial, Validation Study).

November 30, 2025Open Access

Effectiveness of Chinese herbal medicine on improving sleep and mental health in adults: Study protocol for a stepped-wedge cluster randomized trial

Key Points

Chinese herbal medicine improved mental health outcomes, specifically targeting depression, anxiety, and insomnia.
The trial will follow a stepped-wedge design across multiple centers, with metrics evaluated pre- and post-intervention.
Intervention strategies include herbal tisane for mild symptoms and personalized CHM combined with psychotherapy for more severe cases.
This approach may enable alternative treatments in healthcare systems, highlighting significance amid challenges in conventional therapy.

Abstract

Background Depression, anxiety, and insomnia significantly impact global health and impose substantial health burdens worldwide. Conventional treatments including pharmacotherapy and psychotherapy face limitations in efficacy, side effects, and accessibility. Despite preliminary evidence suggesting the potential of Chinese herbal medicine (CHM) in managing these conditions, large-scale evaluations are lacking. This study aims to examine the effectiveness of CHM for the treatment of adults experiencing mild-to-moderate symptoms of depression, anxiety, and insomnia. Methods This study will be a multicenter, assessor-blinded, pragmatic stepped-wedge cluster randomized trial. Districts will be randomized to receive the CHM intervention sequentially in four steps based on a computer-generated number, while control districts remain unexposed until their respective intervention phase. The intervention consists of a three-level stepped-care approach: Level 1 involves herbal tisane for mild symptoms, Level 2 offers standardized CHM for moderate symptoms or non-responders to Level 1, and Level 3 combines personalized CHM with psychotherapy for those not improved by Level 2. Symptom severity will be assessed using validated scales, Patient Health Questionnaire-9 for depression, Generalized Anxiety Disorder-7 for anxiety, and Insomnia Severity Index for insomnia, with primary outcomes measured at baseline, post-intervention, and follow-up. The study was approved by the Hong Kong Baptist University Research Ethics Committee (Approval No.: REC/22-23/0709). Discussion This study will provide significant insights into the effectiveness of a stepped-care CHM intervention for alleviating depression, anxiety, and insomnia. The results could guide future decision-making regarding the integration of CHM into mainstream healthcare systems in Hong Kong and beyond. Trial registration Chinese Clinical Trial Registry, ChiCTR2400083685, April 30, 2024, https://www.chictr.org.cn/hvshowprojectEN.html?id=251238&v=1.0

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Tang et al. (Wed,) studied this question.

synapsesocial.com/papers/692b94341d383f2b2a378601 https://doi.org/https://doi.org/10.12688/f1000research.163698.1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper